Induction of pustular lesions during infliximab therapy for Crohn's disease

Acta Dermato-Venereologica

Volumn 88, Issue 3, 2008, Pages 292-293

  Pérez Pérez, Lidia ^a   Caeiro, José Luis ^a   Fabeiro, José María ^a   Allegue, Francisco ^a   Zulaica, Ander ^a  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; C REACTIVE PROTEIN; CALCIPOTRIOL; INFLIXIMAB;

ADULT; ANUS FISTULA; CASE REPORT; CROHN DISEASE; DRUG WITHDRAWAL; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN TISSUE; LETTER; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; PUSTULOSIS; SKIN BIOPSY;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DRUG ERUPTIONS; GASTROINTESTINAL AGENTS; HUMANS; MALE;

EID: 44349115170     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0425     Document Type: Letter

References (11)

1. Roux CH, Brocq O, Leccia N, Breuil V, Giacchero D, Albert C et al. New onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol 2007; 34: 434-437.
2. Lebas D, Staumont-Sallé D, Solau-Gervais E, Flipo RM, Delaporte E. Manifestations cutanées observées au tours d'un traitment par anti-TNF alpha: 11 observations. Ann Dermatol Venereol 2007; 134: 337-342.
3. Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H. Psoriasiform and pustular eruption induced by infliximab. J Dermatol 2007; 34: 468-472.
4. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy. A paradoxical adverse effect. Arthritis Rheum 2005; 52: 2513-2518.
5. Grinblat B, Scheinberg M. The enigmatic development of psoriasis and psoriasiforme lesions during anti-TNF therapy: a review. Semin Arthritis Rheum 2007; 17. (Epub ahead of print).
6. Krug M, Wünsche A, Blum A. Tabakabhängigkeit und die Folgen auf die Haut. Hautarzt 2004; 55: 301-316.
7. Ahmad K, Rogers S. Development of Crohn's disease in a patient on etanercept for psoriasis. Br J Dermatol 2007; 157: 396.
8. Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, et al. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists. Ann Rheum 2006; 65: 405-407.
9. Dereure O, Guillot B, Jorgensen C, Cohen JD, Combes B, Guilhou JJ. Psoriatic lesions induced by antitumour necrosis factor-α treatment: two cases. Br J Dermatol 2004; 150: 506-507.
10. Verea MM, Del Pozo J, Yebra-Pimentel MT, Porta A, Fonseca E. Psoriasiform eruption induced by infliximab. Ann Pharmacother 2004; 38: 54-57.
11. Michaelson G, Kajermo U, Michaelson A, Hagforsen E. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-α in the normal palmar eccrine sweat duct? Br J Dermatol 2005; 153: 1120-1121.